NewGen Pharma's primary business focus is patient-centered, with a particular emphasis on innovative biotechnological drugs that face access and supply challenges due to the small number of affected patients.

These drugs are typically developed for rare and orphan diseases, and achieving access to treatment can be a significant challenge. The company aims to overcome these supply difficulties and improve patients' lives by developing innovative solutions and global strategies, ensuring broader access to these medications for a larger patient population.